IUI With Letrozole Versus in Natural Cycle

Status Recruiting

Clinical Trial Summary

Rationale Intrauterine insemination (IUI) is the treatment of first choice for couples with unexplained and mild male factor infertility in many countries, but it is controversial whether ovarian stimulation improves fertility outcomes. In recent retrospectively collected data, we found that in couples with unexplained and mild male factor infertility undergoing IUI, ovarian stimulation with letrozole increased live birth rate as compared to natural cycle IUI without substantially increasing the multiple pregnancy rate. We therefore intend to perform a randomized clinical trial (RCT) on the subject in five reproductive medical centers in different cities in China. Objective To test the hypothesis that in couples with unexplained or mild male factor infertility scheduled for an IUI program ovarian stimulation with letrozole increases the live birth rate as compared to natural cycle treatment. Study design Multicenter randomized controlled trial. Study population Women diagnosed with unexplained or mild male factor infertility scheduled for treatment with IUI. Intervention Women will be randomized for ovarian stimulation with letrozole or to natural cycle IUI. In the group allocated to ovarian stimulation, women will receive oral tablets letrozole 5 mg daily from cycle day 3 for 5 days. We will treat the couples for 3 cycles, with a time horizon of 4 months. Main study parameters/endpoints Primary outcome is live birth resulting from conception within 4 months after randomization. Secondary endpoints are clinical pregnancy, multiple pregnancy, miscarriage rates, pregnancy complications, time to pregnancy leading to live birth. Nature and extent of the burden and risks associated with participation, benefit and group relatedness The strategies compared are already broadly applied in current practice. No additional risks are expected. There is no benefit for participants, but the results may benefit future infertile couples.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04169451
Study type	Interventional
Source	Peking University Third Hospital
Contact	Shuo Huang
Phone	86-13601203410
Email	homelyleaf@aliyun.com
Status	Recruiting
Phase	N/A
Start date	September 29, 2022
Completion date	June 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01672801` - Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT	N/A
Completed	`NCT01232465` - Impact of Sperm DNA Integrity on In Vitro Cycles	N/A
Not yet recruiting	`NCT01237535` - Luteal Phase Support With Progesterone Versus Estrogen and Progesterone on Pregnancy Rates	Phase 4
Completed	`NCT02272439` - Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan	N/A
Terminated	`NCT00650754` - Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility	Phase 2/Phase 3
Recruiting	`NCT04754243` - New Protocol in Unexplained Infertility	Phase 4
Completed	`NCT03018314` - Serum Kisspeptin Levels in Infertile Women	N/A
Completed	`NCT02488434` - The Effects of Using Fertile Chip in Sperm Selection for Intracytoplasmic Sperm Injection in Unexplained Infertility	Phase 3
Completed	`NCT02739516` - Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility	Phase 3
Completed	`NCT02628756` - Endometrial Injury in Women With Unexplained Infertility	N/A
Completed	`NCT01044862` - Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation	Phase 3
Recruiting	`NCT03386552` - A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility	Phase 2
Completed	`NCT04465045` - Unexplained Infertility Treated by Hysteroscopy-laparoscopy
Completed	`NCT03461601` - Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility	N/A
Completed	`NCT01859520` - Swim up and Gradient Methods Used in Assisted Reproduction Techniques on DNA Fragmentation of Spermatozoa	N/A
Active, not recruiting	`NCT03828786` - Uterine Scratching in Intra-Uterine Insemination	N/A
Completed	`NCT03397693` - Assessment of Endometrial Thickness & Subendometrial Perfusion by 3D Power Doppler in Women With Unexplained Infertility and PCOS.
Withdrawn	`NCT04955574` - Probiotic and Antibiotic Therapies in Women With Unexplained Infertility	Phase 2
Not yet recruiting	`NCT03398993` - Effect of Endometrial Injury in Couples With Unexplained Infertility	N/A
Completed	`NCT02861105` - The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.